VanEck Associates’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Sell |
6,980
-148,165
| -96% | -$5.33M | ﹤0.01% | 1233 |
|
|
2025
Q1 | $6.12M | Buy |
155,145
+14,991
| +11% | +$591K | 0.01% | 636 |
|
|
2024
Q4 | $4.22M | Buy |
+140,154
| New | +$4.22M | 0.01% | 749 |
|
|
2021
Q2 | – | Sell |
-35,483
| Closed | -$1.71M | – | 1313 |
|
|
2021
Q1 | $1.71M | Buy |
+35,483
| New | +$1.71M | ﹤0.01% | 642 |
|